Insulin resistance after oral glucose tolerance testing in patients with major depression - PubMed (original) (raw)
. 1988 Mar;145(3):325-30.
doi: 10.1176/ajp.145.3.325.
Affiliations
- PMID: 2894176
- DOI: 10.1176/ajp.145.3.325
Insulin resistance after oral glucose tolerance testing in patients with major depression
A Winokur et al. Am J Psychiatry. 1988 Mar.
Abstract
An association between affective disorders and alterations in glucose utilization has been recognized. The authors administered a 5-hour oral glucose tolerance test (GTT) to 28 depressed patients and 21 healthy volunteer control subjects and measured serum glucose as well as plasma insulin and glucagon responses. Depressed patients demonstrated significantly higher basal glucose levels, greater cumulative glucose responses after the GTT, and larger cumulative insulin responses after the GTT than control subjects. Values for cumulative glucagon did not significantly differ between groups. These findings indicate the presence of a functional state of insulin resistance during major depressive illness and suggest the presence of a more generalized biological disturbance in some depressed patients.
Similar articles
- Major depression and impaired glucose tolerance.
Weber B, Schweiger U, Deuschle M, Heuser I. Weber B, et al. Exp Clin Endocrinol Diabetes. 2000;108(3):187-90. doi: 10.1055/s-2000-7742. Exp Clin Endocrinol Diabetes. 2000. PMID: 10926314 - Multiple hormonal responses to insulin-induced hypoglycemia in depressed patients and normal volunteers.
Amsterdam JD, Schweizer E, Winokur A. Amsterdam JD, et al. Am J Psychiatry. 1987 Feb;144(2):170-5. doi: 10.1176/ajp.144.2.170. Am J Psychiatry. 1987. PMID: 3544881 - Circadian variation in glucose tolerance and associated changes in plasma insulin and somatostatin levels in normal volunteers.
Verrillo A, de Teresa A, Rucco E. Verrillo A, et al. Boll Soc Ital Biol Sper. 1984 Dec 30;60(12):2261-6. Boll Soc Ital Biol Sper. 1984. PMID: 6152172 - Minor physiological relevance of oral glucose tolerance test.
Kühl C, Vandsted M, Olsen PG. Kühl C, et al. Diabete Metab. 1982 Sep;8(3):203-7. Diabete Metab. 1982. PMID: 6754492 Clinical Trial. - Impaired glucose tolerance in Thai adults: serum insulin profiles after a 75 gram oral glucose load.
Puavilai G, Tiewtranon V, Pensuwan S, Supitak V, Sriphrapradang A, Chanprasertyotin S. Puavilai G, et al. J Med Assoc Thai. 1989 Sep;72(9):498-505. J Med Assoc Thai. 1989. PMID: 2681497
Cited by
- Higher serum chromium level may be associated with the presentation of depression in patients with metabolic dysfunction-associated fatty liver disease: evidence from NHANES survey.
Li X, Xia X, Jiang B, Yao Y, Ding F, Qin S. Li X, et al. Front Psychiatry. 2024 Mar 18;15:1330283. doi: 10.3389/fpsyt.2024.1330283. eCollection 2024. Front Psychiatry. 2024. PMID: 38563024 Free PMC article. - Behavioral health disorders related to nonalcoholic steatohepatitis.
Sharma A, Albhaisi S, Sanyal AJ. Sharma A, et al. Clin Liver Dis (Hoboken). 2022 Jul 16;20(2):43-47. doi: 10.1002/cld.1211. eCollection 2022 Aug. Clin Liver Dis (Hoboken). 2022. PMID: 36033424 Free PMC article. Review. - Does fructose have a protective role on migraine?-experimental evidence in a rat model of metabolic syndrome under omega-3 supplementation.
Barbosa IR, da Cunha G, Silva RBM, Freitas RDS, Dagnino APA, Campos MM. Barbosa IR, et al. Ann Transl Med. 2022 Apr;10(8):435. doi: 10.21037/atm-21-5699. Ann Transl Med. 2022. PMID: 35571449 Free PMC article. - Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk.
Ismaiel A, Spinu M, Leucuta DC, Popa SL, Chis BA, Fadgyas Stanculete M, Olinic DM, Dumitrascu DL. Ismaiel A, et al. J Clin Med. 2022 Apr 28;11(9):2488. doi: 10.3390/jcm11092488. J Clin Med. 2022. PMID: 35566616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical